Resulting technology, called SafeGuide, will enable faster, more cost-effective development of gene edited therapies like CRISPR BOSTON & CHICAGO & CAMBRIDGE, England, July 10, 2025--(BUSINESS ...
BOSTON & CAMBRIDGE, England, February 06, 2025--(BUSINESS WIRE)--Broken String Biosciences ("Broken String"), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program ...
Broken String Biosciences launched an early access program (EAP) through which select developers of gene edited therapeutics will be able to use Broken String’s INDUCE-seq ® technology in their own ...
Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization Broken String Biosciences (“Broken String”), ...
Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program (EAP) for developers of gene-edited therapies that allow for the ...
Broken String's new INDUCE-seq Early Access Program enables detection of on- and off-target edits at high resolution in days, in your lab Replaces months-long process of building technology pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback